Pharmacy

At a private dinner hosted by JPMorgan Chase Chairman and CEO Jamie Dimon with pharma executives this week before the bank's San Francisco healthcare conference, Amazon was a hot topic of conversation, but Mr. Dimon revealed little about the goals…

For his first act as California's new governor, Gavin Newsom signed an executive order calling for state officials to establish a single-purchaser system for prescription drugs, according to Reuters.

Sun Pharma is voluntarily recalling 13,918 cartons of its vecuronium bromide injection, a muscle relaxer used as part of general anesthesia, in the U.S., according to The Hindu Business Line.

In October, Amgen cut the price of a biweekly dose of its cholesterol drug Repatha by 60 percent. Now, the drugmaker has announced another 60 percent price slash, this time to the cost of a monthly dose, according to a…

Eli Lilly began posting list prices online for its television-advertised drugs Jan. 8, according to The Hill.

David Martin, PharmD, clinical director of the pharmacy department at the 346-bed Gadsden (Ala.) Regional Medical Center, spoke with Becker's Hospital Review about challenges pharmacy leaders must overcome and his advice for managing drug spend. Gadsden Regional is owned by Franklin, Tenn.-based…

Bluebird Bio, a Cambridge, Mass.-based biotechnology company, is proposing a new strategy to pay for the expected seven-figure price of its new experimental gene therapy —  installments, according to The Wall Street Journal.  

Takeda finalized its $62 billion acquisition of Shire Jan. 8, catapulting the Japanese company into a new league of pharma giants, according to Bloomberg.

The FDA plans to establish the Office of Drug Evaluation Science to improve and modernize the review process for new medications, according to STAT.

The U.S. Supreme Court seems unlikely to reject a common legal strategy drugmakers use to defend themselves against patient lawsuits, according to STAT.